WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Inyoung Choi
Patent Agent
Patents and Innovations
Washington, D.C.
ichoi@wsgr.com

D202-920-8761

Download vCard
Open PDF

Inyoung Choi is a patent agent in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovation practice. Her practice focuses on patent prosecution and intellectual property matters, primarily in cancer immunotherapy, immunology, gene editing, and molecular biology.

Prior to joining Wilson Sonsini, Inyoung was consultant at Booz Allen Hamilton, where she delivered enterprise-wide solutions to support the FDA with implementation of novel technical solution and strategy to modernize and transform regulatory review processes across multiple offices within CDER - Office of New Drugs (OND). She has extensive knowledge of the FDA regulatory process and drug approval process. Inyoung completed her doctorate degree at the University of Southern California and post-doctoral fellowship at the University of California, Los Angeles, where she studied molecular control of autoimmune diseases, antitumor immunity, and developed gene and cell-based cancer immunotherapy.

Experience

Inyoung Choi is a patent agent in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovation practice. Her practice focuses on patent prosecution and intellectual property matters, primarily in cancer immunotherapy, immunology, gene editing, and molecular biology.

Prior to joining Wilson Sonsini, Inyoung was consultant at Booz Allen Hamilton, where she delivered enterprise-wide solutions to support the FDA with implementation of novel technical solution and strategy to modernize and transform regulatory review processes across multiple offices within CDER - Office of New Drugs (OND). She has extensive knowledge of the FDA regulatory process and drug approval process. Inyoung completed her doctorate degree at the University of Southern California and post-doctoral fellowship at the University of California, Los Angeles, where she studied molecular control of autoimmune diseases, antitumor immunity, and developed gene and cell-based cancer immunotherapy.

Education
  • Ph.D., Genetic, Molecular, and Cellular Biology, University of Southern California, 2016
  • B.S., Biochemistry, University of California, Los Angeles, 2010
Admissions
  • U.S. Patent and Trademark Office
Credentials
Education
  • Ph.D., Genetic, Molecular, and Cellular Biology, University of Southern California, 2016
  • B.S., Biochemistry, University of California, Los Angeles, 2010
Admissions
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author, “Targeting Monoamine Oxidase A for T Cell-Based Cancer Immunotherapy,” 6(59) Science Immunology, 2021
  • Lead author, “Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology,” 26(10) Cell Reports 2704-2719, 2019
  • Co-author, “MicroRNA-146a Modulates Autoreactive Th17 Cell Differentiation and Regulates Organ-Specific Autoimmunity,” 127(10) The Journal of Clinical Investigation 3702-3716, 2017
  • Lead author, “Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune disease and immunosenescence,” 455 Molecular and Cellular Endocrinology 4-12, 2017
  • Lead author, “A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms,” 15 Cell Reports 2036-2146, 2016
  • Lead author, “A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan,” 22 Cell Metabolism 1-14, 2015
  • Co-author, “Genetic Analysis of Fibroblast Growth Factor Signaling in the Drosophila Eye,” 2 G3 23-28, 2012
Insights

Select Publications

  • Co-author, “Targeting Monoamine Oxidase A for T Cell-Based Cancer Immunotherapy,” 6(59) Science Immunology, 2021
  • Lead author, “Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology,” 26(10) Cell Reports 2704-2719, 2019
  • Co-author, “MicroRNA-146a Modulates Autoreactive Th17 Cell Differentiation and Regulates Organ-Specific Autoimmunity,” 127(10) The Journal of Clinical Investigation 3702-3716, 2017
  • Lead author, “Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune disease and immunosenescence,” 455 Molecular and Cellular Endocrinology 4-12, 2017
  • Lead author, “A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms,” 15 Cell Reports 2036-2146, 2016
  • Lead author, “A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan,” 22 Cell Metabolism 1-14, 2015
  • Co-author, “Genetic Analysis of Fibroblast Growth Factor Signaling in the Drosophila Eye,” 2 G3 23-28, 2012

Biological Sciences and Biotechnology

  • Antibody
  • Cancer biology
  • Cancer therapeutics
  • CAR-T cells
  • Cell biology
  • Cell culture products
  • Cell therapy
  • Cellular biology
  • Cellular immunology
  • Epigenetics
  • Genetics
  • Immuno-oncology
  • Immunobiology
  • Immunology
  • Molecular biology
  • Molecular genetics
  • PCR
  • Stem cell biology
  • T and B cell biology
  • T cell biology
  • T cell immunology

Therapeutics and Drug Discovery

  • Antimicrobial agents
  • CRISPR
  • Drug conjugates
  • Drug delivery
  • Gene editing
  • Gene therapy
  • Immunotherapy targets
  • RNA interference (RNAi)
  • Small molecule synthesis

Diagnostics and Medical Devices

  • Bioinformatic
  • Biomedical devices
  • Diagnostics
  • Wearable analyte sensors

Miscellaneous

  • Cancer
  • Engineered foods
  • Food science
  • Formulations
Technical Fluency

Biological Sciences and Biotechnology

  • Antibody
  • Cancer biology
  • Cancer therapeutics
  • CAR-T cells
  • Cell biology
  • Cell culture products
  • Cell therapy
  • Cellular biology
  • Cellular immunology
  • Epigenetics
  • Genetics
  • Immuno-oncology
  • Immunobiology
  • Immunology
  • Molecular biology
  • Molecular genetics
  • PCR
  • Stem cell biology
  • T and B cell biology
  • T cell biology
  • T cell immunology

Therapeutics and Drug Discovery

  • Antimicrobial agents
  • CRISPR
  • Drug conjugates
  • Drug delivery
  • Gene editing
  • Gene therapy
  • Immunotherapy targets
  • RNA interference (RNAi)
  • Small molecule synthesis

Diagnostics and Medical Devices

  • Bioinformatic
  • Biomedical devices
  • Diagnostics
  • Wearable analyte sensors

Miscellaneous

  • Cancer
  • Engineered foods
  • Food science
  • Formulations
Focus Areas
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.